Screening for lung cancer: A review of the current literature Review uri icon

Overview

MeSH Major

  • Lung Neoplasms
  • Mass Screening

abstract

  • The use of either CXR or sputum cytology for the early detection of lung cancer is not supported by the published evidence. The evidence for LDCT appears promising, in that the technology typically identifies lung cancer at an early stage, although corollary studies suggest that these findings in isolation may be misleading. Further high-quality research is needed to better define the role of LDCT in the evaluation of asymptomatic high-risk individuals.

publication date

  • February 4, 2003

Research

keywords

  • Review

Identity

Language

  • eng

PubMed ID

  • 12527566

Additional Document Info

start page

  • 72S

end page

  • 82S

volume

  • 123

number

  • 1 SUPPL.